Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.66 |
| ▸ | CA2 | P00918 | 2/20 | 0.66 |
| ▸ | P2RY6 | Q15077 | 3/20 | 0.53 |
| ▸ | RAD1 | O60671 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | MIF | P14174 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | NT5E | P21589 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 2/20 | 0.45 |
| ▸ | LTA | P01374 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31315339 | 1.00 | CA1 (0.66) | CA1CA2P2RY6RAD1POLB | |
| SCHEMBL1194107 | 0.98 | CA1 (0.63) | CA1CA2P2RY6RAD1POLB | |
| Water SCHEMBL3903037 | 0.96 | CA1 (0.61) | CA1CA2P2RY6RAD1POLB | |
| Bitoscanate SCHEMBL8443297 | 0.87 | CA1 (0.63) | CA1CA2P2RY6RAD1POLB | |
| SCHEMBL483832 | 0.83 | CA1 (0.70) | CA1CA2P2RY6RAD1POLB | |
| SCHEMBL2278953 | 0.81 | POLB (0.53) | CA1CA2P2RY6RAD1POLB | |
| SCHEMBL4350715 | 0.81 | RAD1 (0.51) | CA1CA2P2RY6RAD1POLB | |
| SCHEMBL1476527 | 0.79 | CA2 (1.00) | CA1CA2P2RY6POLBMIF | |
| SCHEMBL2891113 | 0.79 | CA1 (0.66) | CA1CA2P2RY6RAD1MIF | |
| SCHEMBL12433773 | 0.79 | POLB (0.52) | CA1CA2P2RY6RAD1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 239 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11573238-B2 | Means and methods for single molecule peptide sequencing | VIB VZW (BE) | 2023-02-07 | — | — | US | claimed |
| CN-110681495-B | Thiourea compound flotation separation inhibitor and flotation separation method thereof | 北京矿冶科技集团有限公司 | 2021-08-06 | — | — | CN | claimed |
| CN-111840138-A | Fragrant hair care hair dye | 长沙蓝姿生物科技有限公司 | 2020-10-30 | — | — | CN | claimed |
| US-20200231956-A1 | MEANS AND METHODS FOR SINGLE MOLECULE PEPTIDE SEQUENCING | UNIVERSITEIT GENT (BE) | 2020-07-23 | — | — | US | claimed |
| CN-110681495-A | Thiourea compound flotation separation inhibitor and flotation separation method thereof | 北京矿冶科技集团有限公司 | 2020-01-14 | — | — | CN | claimed |
| EP-2441454-B1 | The use of isothiocyanate compounds in treating prostatitis | JC WUXI COMPANY INC (CN) | 2015-09-16 | — | — | EP | claimed |
| EP-1763510-B1 | METHOD FOR SEQUENCING AND QUANTIFYING AMINO ACIDS IN POLYPEPTIDES | UNIV KOREA IND & ACAD COOP (KR) | 2014-06-18 | — | — | EP | claimed |
| US-8410170-B2 | Use of isothiocyanates compounds in treating prostatic diseases and skin cancer | WUXI JC PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2013-04-02 | — | — | US | claimed |
| US-20120125775-A1 | CHEMICAL MODIFICATION OF PROTEINS FOR THEIR MORE ACCURATE MOLECULAR-WEIGHT DETERMINATION BY ELECTROPHORESIS | DOLNIK VLADISLAV (US) | 2012-05-24 | — | — | US | claimed |
| EP-2441454-A1 | The use of isothiocyanates compounds in treating prostatic diseases and skin cancer | Cheng, Jingcai (CN) | 2012-04-18 | — | — | EP | claimed |
| US-20120046358-A1 | USE OF ISOTHIOCYANATES COMPOUNDS IN TREATING PROSTATIC DISEASES AND SKIN CANCER | WUXI JC PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2012-02-23 | — | — | US | claimed |
| US-7732625-B2 | Colorant compounds | XEROX CORPORATION (US) | 2010-06-08 | — | — | US | claimed |
| US-20090005438-A1 | Use of Isothiocyanates Compounds in Treating Prostatic Diseases and Skin Cancer | WUXI JC PHARMACEUTICAL TECHNOLOGY CO., LTD. | 2009-01-01 | — | — | US | claimed |
| EP-1961418-A1 | THE USE OF ISOTHIOCYANATES COMPOUNDS IN TREATING PROSTATIC DISEASES AND SKIN CANCER | Cheng, Jingcai (CN) | 2008-08-27 | — | — | EP | claimed |
| US-7311767-B2 | Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-5962642-A | TREATING PROTEIN/PEPTIDE HAVING AMINO TERMINAL ACETYLATED AMINO ACID WITH ACID TO ACETYLATE HYDROXYL GROUP, TREATING WITH ISOTHIOCYANATE COMPOUND IN PRESENCE OF ACID TO FORM THIOCARBAMYL PROTEIN/PEPTIDE, ANALYSIS BY EDMAN DEGRADATION | SEIKO INSTRUMENTS INC. (JP) | 1999-10-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | CA1 102/4885CA2 32/4885P2RY6 3979/4885 |
| US-20120046358-A1 | USE OF ISOTHIOCYANATES COMPOUNDS IN TREATING PROSTATIC DISEASES AND SKIN CANCER | KLK3, TST, GSTA2 | CA1 3916/4885CA2 2080/4885P2RY6 3908/4885 |
| US-20090005438-A1 | Use of Isothiocyanates Compounds in Treating Prostatic Diseases and Skin Cancer | KLK3, TST, GSTA2 | CA1 3916/4885CA2 2080/4885P2RY6 3908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.